
Bulletin of the Chemical Society of Japan p. 2315 - 2326 (1999)
Update date:2022-07-31
Topics:
Yamamoto, Gaku
Nakajo, Fusako
Tsubai, Natsuko
Murakami, Hiroaki
Mazaki, Yasuhiro
X-Ray crystallographic and dynamic NMR spectroscopic studies were performed on N-9-triptycylacetamide (1), N-methyl-N-9-triptycylacetamide (2), N-ethyl-N-9-triptycylacetamide (3), and N-benzyl-N-9-triptycylacetamide (4). In the crystalline state, compounds 1, 2, and 4 exist solely as the Z-isomer for the amide bond, while equal amounts of the Z- and E-isomers exist in a single crystal of compound 3. The amide nitrogen atom in 2, 3, or 4 is significantly pyramidalized. In solution, 1 exists solely as the Z-isomer, while 2, 3, and 4 exist as an equilibrium mixture of the Z- and E-isomers. The isomer ratio is not correlated with the bulkiness of the N-alkyl group; the N-ethyl compound 3 seems to behave anomalously. The isomer ratio is significantly dependent on the solvent; the population of the Z-isomer in 2 or 3 or 4 increases with the solvent polarity. The Z?E interconversion takes place on the NMR time scale around ambient temperature, and the barrier is dependent on the solvent; hydroxylic solvents, methanol and ethanol, increase the barrier. The methylene protons in the ethyl or benzyl group in any isomer of 3 or 4 become diastereotopic at low temperatures suggesting that the nitrogen atom in either compound is pyramidal in solution. Stereomutation around the Tp-N bond is discussed in some detail.
View MoreJiangsu Fengshan Group Co., Ltd.
Contact:86-25-86558671
Address:1903,Central International Mansion 105-6 North Zhongshan Road, Nanjing, China
website:https://www.yurisolar.com/en
Contact:86--18092602675
Address:No. 560, East Hangtian Road, Xi'an, China
Contact:+65 9658 0999
Address:26 Sin Ming Lane, Midview City, #05-118, Singapore 573971
website:http://www.fwdchem.com
Contact:86-21-54450828
Address:Room 802,Lotus Tower ,159 Tianzhou Road,Xuhui District,Shanghai
A.M FOOD CHEMICAL CO., LIMITED
Contact:86-531-87100375
Address:20Floor,Bblock,1Building,pharma-valley,Jinan,China
Doi:10.1021/ol991166b
(1999)Doi:10.1248/cpb.47.1604
(1999)Doi:10.1021/ol991134o
(1999)Doi:10.1021/acs.jafc.9b02265
(2019)Doi:10.1039/j39690002813
(1969)Doi:10.1002/ejoc.201700073
(2017)